Wednesday May 3rd, 2006
The Jane Mallet Theatre
St. Lawrence Centre
27 Front Street East
Toronto, Ontario
10:00 a.m. EDT
CALGARY, May 2 /CNW/ - The Westaim Corporation will hold its Annual
General Meeting of Shareholders and Investor Briefing on Wednesday, May 3,
2006 at 10:00 a.m. EDT. The meeting will be held at the Jane Mallet Theatre,
St. Lawrence Centre, 27 Front Street East, in downtown Toronto.
Both the meeting and investor briefing will be webcast live at
www.westaim.com. An audio file of the webcast will be archived and posted on
the Westaim website.
The Westaim Corporation's technology investments include: NUCRYST
Pharmaceuticals (NASDAQ: NCST; TSX: NCS), which researches, develops and
commercializes medical devices and pharmaceutical products that fight
infection and inflammation based on its nanocrystalline silver technology; and
iFire Technology, which has developed a revolutionary low-cost flat panel
display. Westaim's common shares are listed on NASDAQ under the symbol WEDX
and on The Toronto Stock Exchange under the trading symbol WED.
%SEDAR: 00002793E
